Skip to main content
Have a personal or library account? Click to login
Chronic Obstructive Pulmonary Disease in Latin America Cover

Chronic Obstructive Pulmonary Disease in Latin America

Open Access
|Jan 2019

References

  1. Murray CJ and Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet. 1997; 349: 14361442. DOI: 10.1016/S0140-6736(96)07495-8
  2. Global Burden of Disease Study 2013. Global burden of disease data download; 2013. http://ghdx.healthdata.org/global-burden-disease-study-2013-gbd-2013-data-downloads. Accessed January 19, 2016.
  3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS and Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (gold) workshop summary. American Journal of Respiratory and Critical Care Medicine. 2001; 163: 12561276. DOI: 10.1164/ajrccm.163.5.2101039
  4. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet. 2005; 366: 18751881. DOI: 10.1016/S0140-6736(05)67632-5
  5. Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (prepocol study). Chest. 2008; 133: 343349. DOI: 10.1378/chest.07-1361
  6. Perez-Padilla R, Vazquez-Garcia JC, Marquez MN and Menezes AM. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respiratory Care. 2008; 53: 10191026.
  7. Perez-Padilla R, Vazquez-Garcia JC, Marquez MN, et al. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respiratory Care. 2006; 51: 11671171.
  8. Rosa FW, Perez-Padilla R, Camelier A, Nascimento OA, Menezes AM and Jardim JR. Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over. Braz J Med Biol Res. 2007; 40: 16151621. DOI: 10.1590/S0100-879X2006005000182
  9. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD. 2007; 4: 113120. DOI: 10.1080/15412550701341012
  10. Perez-Padilla R, Wehrmeister FC, Celli BR, et al. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: The PLATINO longitudinal study. PLoS One. 2013; 8: e67960. DOI: 10.1371/journal.pone.0067960
  11. Talamo C, de Oca MM, Halbert R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007; 131: 6067. DOI: 10.1378/chest.06-1149
  12. Luize AP, Menezes AM, Perez-Padilla R, et al. Assessment of five different guideline indication criteria for spirometry, including modified gold criteria, in order to detect COPD: Data from 5,315 subjects in the PLATINO study. NPJ Primary Care Respiratory Medicine. 2014; 24: 14075. DOI: 10.1038/npjpcrm.2014.75
  13. Moreira GL, Manzano BM, Gazzotti MR, et al. PLATINO, a nine-year follow-up study of COPD in the city of Sao Paulo, Brazil: The problem of underdiagnosis. J Bras Pneumol. 2014; 40: 3037. DOI: 10.1590/S1806-37132014000100005
  14. Nascimento OA, Camelier A, Rosa FW, Menezes AM, Perez-Padilla R and Jardim JR. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in Sao Paulo (Brazil): Results of the PLATINO study. Braz J Med Biol Res. 2007; 40: 887895. DOI: 10.1590/S0100-879X2006005000133
  15. Perez-Padilla R. Would widespread availability of spirometry solve the problem of underdiagnosis of COPD? Int J Tuberc Lung Dis. 2016; 20: 4. DOI: 10.5588/ijtld.15.0893
  16. Lopez Varela MV, de Oca MM, Halbert RJ, et al. Sex-related difference in COPD in five Latin American cities: The PLATINO study. Eur Respir J. 2010; 36: 10341041. DOI: 10.1183/09031936.00165409
  17. Lopez Varela MV, Montes de Oca M, Halbert R, et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: The PLATINO study. Arch Bronconeumol. 2013; 49: 468474. DOI: 10.1016/j.arbr.2013.09.009
  18. Montes de Oca M, Talamo C, Perez-Padilla R, et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: The PLATINO study. Respir Med. 2008; 102: 642650. DOI: 10.1016/j.rmed.2007.12.025
  19. Montes de Oca M, Halbert RJ, Talamo C, et al. Paid employment in subjects with and without chronic obstructive pulmonary disease in five Latin American cities: The PLATINO study. Int J Tuberc Lung Dis. 2011; 15: 12591264. DOI: 10.5588/ijtld.10.0508
  20. de Oca MM, Talamo C, Halbert RJ, et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: The proyecto latinoamericano de investigacion en obstruccion pulmonar (PLATINO) study. Chest. 2009; 136: 7178. DOI: 10.1378/chest.08-2081
  21. Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014; 145: 297304. DOI: 10.1378/chest.13-0622
  22. Laniado-Laborin R, Rendon A and Bauerle O. Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population. Int J Tuberc Lung Dis. 2011; 15: 818823. DOI: 10.5588/ijtld.10.0546
  23. Schiavi E, Stirbulov R, Hernandez Vecino R, Mercurio S, Di Boscio V and Puma T. COPD screening in primary care in four Latin American countries: Methodology of the puma study. Arch Bronconeumol. 2014; 50: 469474. DOI: 10.1016/j.arbres.2014.03.006
  24. Montes de Oca M, Victorina Lopez Varela M, Laucho-Contreras ME, Casas A, Schiavi E and Mora JC. Asthma-COPD overlap syndrome (acos) in primary care of four Latin America countries: The puma study. BMC Pulmonary Medicine. 2017; 17: 69. DOI: 10.1186/s12890-017-0414-6
  25. Montes de Oca M, Lopez Varela MV, Laucho-Contreras ME, et al. Classification of patients with chronic obstructive pulmonary disease according to the Latin American thoracic association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (gold). Arch Bronconeumol. 2017; 53: 98106. DOI: 10.1016/j.arbres.2016.08.015
  26. Casas Herrera A, Montes de Oca M, Lopez Varela MV, et al. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: The puma study. PLoS One. 2016; 11: e0152266. DOI: 10.1371/journal.pone.0152266
  27. Perez-Padilla R, Vollmer WM, Vazquez-Garcia JC, Enright PL, Menezes AM and Buist AS. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis. 2009; 13: 387393.
  28. Franco-Marina F, Fernandez-Plata R, Torre-Bouscoulet L, et al. Efficient screening for COPD using three steps: A cross-sectional study in Mexico city. NPJ Primary Care Respiratory Medicine. 2014; 24: 14002. DOI: 10.1038/npjpcrm.2014.2
  29. Bruse S, Sood A, Petersen H, et al. New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. American Journal of Respiratory and Critical Care Medicine, 2011; 184: 12541260. DOI: 10.1164/rccm.201103-0568OC
  30. Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014; 311: 183192. DOI: 10.1001/jama.2013.284692
  31. Perez-Rubio G, Jimenez-Valverde LO, Ramirez-Venegas A, et al. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values. Arch Bronconeumol. 2015; 51: 8085. DOI: 10.1016/j.arbr.2014.11.002
  32. Hernandez-Montoya J, Perez-Ramos J, Montano M, et al. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population. Biomarkers in Medicine. 2015; 9: 979988. DOI: 10.2217/bmm.15.75
  33. Resendiz-Hernandez JM, Sansores RH, Hernandez-Zenteno Rde J, et al. Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity. International Journal of Chronic Obstructive Pulmonary Disease. 2015; 10: 12411251.
  34. Perez-Padilla R, Fernandez R, Lopez Varela MV, et al. Airflow obstruction in never smokers in five Latin American cities: The PLATINO study. Archives of Medical Research. 2012; 43: 159165. DOI: 10.1016/j.arcmed.2012.03.007
  35. Menezes AMB, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: Evidence from the PLATINO study in Latin America. European Respiratory Journal. 2007; 30: 11801185. DOI: 10.1183/09031936.00083507
  36. Postma DS, Bush A and van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015; 385: 899909. DOI: 10.1016/S0140-6736(14)60446-3
  37. de la Mora IL, Martinez-Oceguera D and Laniado-Laborin R. Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life. Int J Tuberc Lung Dis. 2015; 19: 808810. DOI: 10.5588/ijtld.14.0983
  38. Bonjour S, Adair-Rohani H, Wolf J, et al. Solid fuel use for household cooking: Country and regional estimates for 1980–2010. Environmental Health Perspectives. 2013; 121: 784790. DOI: 10.1289/ehp.1205987
  39. Smith KR, Bruce N, Balakrishnan K, et al. Millions dead: How do we know and what does it mean? Methods used in the comparative risk assessment of household air pollution. Annual Review of Public Health. 2014; 35: 185206. DOI: 10.1146/annurev-publhealth-032013-182356
  40. Burnett RT, Pope CA, 3rd, Ezzati M, et al. An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environmental Health Perspectives. 2014; 122: 397403. DOI: 10.1289/ehp.1307049
  41. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low- and middle-income countries. The Lancet Respiratory Medicine. 2014; 2: 823860. DOI: 10.1016/S2213-2600(14)70168-7
  42. Bruce N, Perez-Padilla R and Albalak R. Indoor air pollution in developing countries: A major environmental and public health challenge. Bull World Health Organ. 2000; 78: 10781092.
  43. Smith KR. Biofuels, Air Pollution, and Health. New York: Plenum Press; 1987.
  44. Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M and Viegi G. Biomass fuels and respiratory diseases: A review of the evidence. Proc Am Thorac Soc. 2008; 5: 577590. DOI: 10.1513/pats.200707-100RP
  45. Liu Y, Lee K, Perez-Padilla R, Hudson NL and Mannino DM. Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries. Int J Tuberc Lung Dis. 2008; 12: 115127.
  46. Diette GB, Accinelli RA, Balmes JR, et al. Obstructive lung disease and exposure to burning biomass fuel in the indoor environment. Glob Heart. 2012; 7: 265270. DOI: 10.1016/j.gheart.2012.06.016
  47. Restrepo J, Reyes P, De Ochoa P and Patiño E. Neumoconiosis por inhalación del humo de leña. Acta Medica Colombiana. 1983; 8: 191204.
  48. Sandoval J, Salas J, Martinez-Guerra ML, et al. Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest. 1993; 103: 1220. DOI: 10.1378/chest.103.1.12
  49. Bruce N, Perez-Padilla R and Albalak R. The health effects of indoor air pollution exposure in developing countries. Geneva: World Health Organization. 2002; 11.
  50. Desai M, Mehta S and Smith K. Indoor smoke from solid fuels. Assessing the environmental burden of disease at national and local levels. Geneva: World Health Organization; 2004.
  51. Ramirez-Venegas A, Sansores RH, Quintana-Carrillo RH, et al. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. American Journal of Respiratory and Critical Care Medicine. 2014; 190: 9961002. DOI: 10.1164/rccm.201404-0720OC
  52. Zhou Y, Zou Y, Li X, et al. Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: A 9-year prospective cohort study. PLoS Medicine. 2014; 11: e1001621. DOI: 10.1371/journal.pmed.1001621
  53. Camp PG, Ramirez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J. 2014; 43: 725734. DOI: 10.1183/09031936.00206112
  54. Moran-Mendoza O, Perez-Padilla JR, Salazar-Flores M and Vazquez-Alfaro F. Wood smoke-associated lung disease: A clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis. 2008; 12: 10921098.
  55. Perez-Padilla R, Ramirez-Venegas A and Sansores-Martinez R. Clinical characteristics of patients with biomass smoke-associated COPD and chronic bronchitis. J COPD F. 2014; 1: 2332. DOI: 10.15326/jcopdf.1.1.2013.0004
  56. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. American Journal of Respiratory and Critical Care Medicine. 2006; 173: 393397. DOI: 10.1164/rccm.200504-568OC
  57. Gonzalez-Garcia M, Maldonado Gomez D, Torres-Duque CA, et al. Tomographic and functional findings in severe COPD: Comparison between the wood smoke-related and smoking-related disease. J Bras Pneumol. 2013; 39: 147154. DOI: 10.1590/S1806-37132013000200005
  58. Gonzalez-Garcia M, Torres-Duque CA, Bustos A, Jaramillo C and Maldonado D. Bronchial hyperresponsiveness in women with chronic obstructive pulmonary disease related to wood smoke. International Journal of Chronic Obstructive Pulmonary Disease. 2012; 7: 367373. DOI: 10.2147/COPD.S30410
  59. González-García M, Páez S, Jaramillo C, Barrero M and Maldonado D. Enfermedad pulmonar obstructiva crónica por humo de leña en mujeres. Comparación con la epoc por tabaquismo Acta Med Colomb. 2004; 29: 1725.
  60. Moreira MA, Barbosa MA, Queiroz MC, et al. Pulmonary changes on HRCT scans in nonsmoking females with COPD due to wood smoke exposure. J Bras Pneumol. 2013; 39: 155163. DOI: 10.1590/S1806-37132013000200006
  61. Moreira MA, Moraes MR, Silva DG, et al. Comparative study of respiratory symptoms and lung function alterations in patients with chronic obstructive pulmonary disease related to the exposure to wood and tobacco smoke. J Bras Pneumol. 2008; 34: 667674. DOI: 10.1590/S1806-37132008000900006
  62. Rivera RM, Cosio MG, Ghezzo H, Salazar M and Perez-Padilla R. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis. 2008; 12: 972977.
  63. Arenas JL, Murillo A, Seoane M and Lupi Herrera E. Radiologic indices and measurements in the evaluation of pulmonary artery hypertension in chronic obstructive lung disease. Arch Inst Cardiol Mex. 1983; 53: 187190.
  64. Lupi-Herrera E, Sandoval J, Seoane M and Bialostozky D. Behavior of the pulmonary circulation in chronic obstructive pulmonary disease. Pathogenesis of pulmonary arterial hypertension at an attitude of 2,240 meters. Am Rev Respir Dis. 1982; 126: 509514.
  65. Lupi-Herrera E, Seoane M and Verdejo J. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. Chest. 1984; 85: 156163. DOI: 10.1378/chest.85.2.156
  66. Menezes AMB, Perez-Padilla R, Jardim JRB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet. 2005; 366: 18751881. DOI: 10.1016/S0140-6736(05)67632-5
  67. Nocturnal Oxygen Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Nocturnal oxygen therapy trial group. Annals of Internal Medicine. 1980; 93: 391398. DOI: 10.7326/0003-4819-93-3-391
  68. Perez-Padilla R, Torre-Bouscoulet L, Muino A, et al. Prevalence of oxygen desaturation and use of oxygen at home in adults at sea level and at moderate altitude. Eur Respir J. 2006; 27: 594599. DOI: 10.1183/09031936.06.00075005
  69. Menezes AM, Muino A, Lopez-Varela MV, et al. A population-based cohort study on chronic obstructive pulmonary disease in Latin America: Methods and preliminary results. The PLATINO study phase ii. Arch Bronconeumol. 2014; 50: 1017. DOI: 10.1016/j.arbres.2013.07.014
  70. Menezes AM, Perez-Padilla R, Wehrmeister FC, et al. FEV1 is a better predictor of mortality than FVC: The PLATINO cohort study. PLoS One. 2014; 9: e109732. DOI: 10.1371/journal.pone.0109732
  71. Casanova C, de Torres JP, Aguirre-Jaime A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: The experience of the bode cohort. American Journal of Respiratory and Critical Care Medicine. 2011; 184: 10151021. DOI: 10.1164/rccm.201105-0831OC
  72. Reynales-Shigematsu LM. Literature review of health care costs of diseases attributable to tobacco consumption in the Americas. Salud Publica de Mexico. 2006; 48(1): S190200. DOI: 10.1590/S0036-36342006000700023
  73. Reynales-Shigematsu LM, Rodriguez-Bolanos Rde L, Jimenez JA, Juarez-Marquez SA, Castro-Rios A and Hernandez-Avila M. Health care costs attributable to tobacco consumption on a national level in the Mexican social security institute. Salud Publica de Mexico. 2006; 48(1): S4864. DOI: 10.1590/S0036-36342006000700007
  74. Perez AN, Murillo MR and Pinzon FC and Hernández G. Costos de la atención médica del cáncer de pulmón, la epoc y el iam atribuibles al consumo de tabaco en Colombia. Rev Col Cancerol. 2007; 11: 241249.
  75. Maquilon C, Chiong H, Bello S, Naranjo C, Lira P and Diaz M. Comparative study of health care costs for patients using home oxygen therapy or those in waiting lists. Rev Med Chil. 2001; 129: 13951403. DOI: 10.4067/S0034-98872001001200005
  76. Montes de Oca M, Lopez Varela MV, Acuna A, et al. ALAT-2014 chronic obstructive pulmonary disease (COPD) clinical practice guidelines: Questions and answers. Arch Bronconeumol. 2015; 51: 403416. DOI: 10.1016/j.arbres.2014.11.017
  77. Anzueto A, Jardim JR, Lopez H, et al. ALAT (Latin American thoracic association) recommendations on infectious exacerbation of COPD. Arch Bronconeumol. 2001; 37: 349357. DOI: 10.1016/S0300-2896(01)75105-8
  78. Peces-Barba G, Barbera JA, Agusti A, et al. Diagnosis and management of chronic obstructive pulmonary disease: Joint guidelines of the Spanish society of pulmonology and thoracic surgery (separ) and the Latin American thoracic society (ALAT). Arch Bronconeumol. 2008; 44: 271281. DOI: 10.1157/13119943
  79. Lopez Varela MV, Muino A, Perez Padilla R, et al. Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: The PLATINO study. Arch Bronconeumol. 2008; 44: 5864. DOI: 10.1016/S1579-2129(08)60016-6
  80. Montes de Oca M, Talamo C, Perez-Padilla R, et al. Use of respiratory medication in five Latin American cities: The PLATINO study. Pulm Pharmacol Ther. 2008; 21: 788793. DOI: 10.1016/j.pupt.2008.06.003
  81. Cynthia AA, Edwards RD, Johnson M, et al. Reduction in personal exposures to particulate matter and carbon monoxide as a result of the installation of a patsari improved cook stove in michoacan Mexico. Indoor Air. 2008; 18: 93105. DOI: 10.1111/j.1600-0668.2007.00509.x
  82. Chafe ZA, Brauer M, Klimont Z, et al. Household cooking with solid fuels contributes to ambient pm2.5 air pollution and the burden of disease. Environmental Health Perspectives. 2014; 122: 13141320. DOI: 10.1289/ehp.1206340
  83. Romieu I, Riojas-Rodriguez H, Marron-Mares AT, Schilmann A, Perez-Padilla R and Masera O. Improved biomass stove intervention in rural Mexico: Impact on the respiratory health of women. American Journal of Respiratory and Critical Care Medicine. 2009; 180: 649656. DOI: 10.1164/rccm.200810-1556OC
  84. Aisanov Z, Bai C, Bauerle O, et al. Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. International Journal of Chronic Obstructive Pulmonary Disease. 2012; 7: 271282.
  85. Laniado-Laborin R, Rendon A, Alcantar-Schramm JM, Cazares-Adame R and Bauerle O. Subutilization of COPD guidelines in primary care: A pilot study. Journal of Primary Care & Community Health. 2013; 4: 172176 DOI: 10.1177/2150131913475817
  86. Bateman E, Feldman C, Mash R, Fairall L, English R and Jithoo A. Systems for the management of respiratory disease in primary care—An international series: South Africa. Prim Care Respir J. 2009; 18: 6975. DOI: 10.3132/pcrj.2009.00009
  87. Bheekie A, Buskens I, Allen S, et al. The practical approach to lung health in South Africa (palsa) intervention: Respiratory guideline implementation for nurse trainers. Int Nurs Rev. 2006; 53: 261268. DOI: 10.1111/j.1466-7657.2006.00520.x
  88. Murray JF, Pio A and Ottmani S. Pal: A new and practical approach to lung health. Int J Tuberc Lung Dis. 2006; 10: 11881191.
  89. Camacho M, Nogales M, Manjon R, Del Granado M, Pio A and Ottmani S. Results of pal feasibility test in primary health care facilities in four regions of Bolivia. Int J Tuberc Lung Dis. 2007; 11: 12461252.
  90. Pietinalho A, Kinnula VL, Sovijarvi AR, et al. Chronic bronchitis and chronic obstructive pulmonary disease. The finnish action programme, interim report. Respir Med. 2007; 101: 14191425. DOI: 10.1016/j.rmed.2007.01.022
  91. Perez-Padilla R, Stelmach R, Soto-Quiroz M and Cruz AA. Fighting respiratory diseases: Divided efforts lead to weakness. J Bras Pneumol. 2014; 40: 207210. DOI: 10.1590/S1806-37132014000300001
  92. Declaration of alma-ata. WHO Chron. 1978; 32: 428430.
  93. Regalado J, Perez-Padilla R, Sansores R, et al. The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. American Journal of Respiratory and Critical Care Medicine. 2006; 174: 901905. DOI: 10.1164/rccm.200503-479OC
  94. Montano M, Beccerril C, Ruiz V, Ramos C, Sansores RH and Gonzalez-Avila G. Matrix metalloproteinases activity in COPD associated with wood smoke. Chest. 2004; 125: 466472. DOI: 10.1378/chest.125.2.466
  95. Montano M, Cisneros J, Ramirez-Venegas A, et al. Malondialdehyde and superoxide dismutase correlate with fev(1) in patients with COPD associated with wood smoke exposure and tobacco smoking. Inhalation Toxicology. 2010; 22: 868874. DOI: 10.3109/08958378.2010.491840
  96. Montano M, Sansores RH, Becerril C, et al. FEV1 inversely correlates with metalloproteinases 1, 7, 9 and crp in COPD by biomass smoke exposure. Respiratory Research. 2014; 15: 74.
  97. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, Ochoa L, Hernandez-Zenteno R and Sansores RH. Increase of th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med. 2011; 105: 16481654. DOI: 10.1016/j.rmed.2011.05.017
  98. Solleiro-Villavicencio H, Quintana-Carrillo R, Falfan-Valencia R and Vargas-Rojas MI. Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a th2 cytokine production profile. Clinical Immunology. 2015; 161: 150155. DOI: 10.1016/j.clim.2015.07.009
  99. Sansores Martinez R and Ramirez-Venegas A. Consenso mexicano sobre epoc. Neumologia y Cirugia de Torax. 2007; 66: 1150.
DOI: https://doi.org/10.5334/aogh.2418 | Journal eISSN: 2214-9996
Language: English
Published on: Jan 22, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Rogelio Perez-Padilla, Ana Maria B. Menezes, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.